ClinConnect ClinConnect Logo
Search / Trial NCT06940258

Caval Aorta Index for Fluid Optimization in Traumatic Brain Injury

Launched by MANSOURA UNIVERSITY · Apr 15, 2025

Trial Information

Current as of July 01, 2025

Not yet recruiting

Keywords

Caval Aorta Index Traumatic Brain Injury

ClinConnect Summary

This clinical trial, titled "Caval Aorta Index for Fluid Optimization in Traumatic Brain Injury," aims to improve the care of patients with traumatic brain injuries (TBI). TBIs can lead to serious health issues, and it’s crucial to manage them effectively to prevent further harm. The researchers are looking at a specific method to help balance fluid in the body, which is important for ensuring the brain gets enough blood and oxygen.

To participate in this trial, candidates must be between the ages of 18 and 60 and have a confirmed diagnosis of TBI through a brain scan. They should be admitted to the hospital within 24 hours of their injury and have a certain level of alertness as measured by a standard scoring system. However, some individuals may not be eligible, such as those with certain other health conditions or those who require other surgeries soon after their injury. If eligible, participants can expect to be closely monitored and receive specific treatments aimed at improving their recovery. This trial is currently not yet recruiting participants, but it represents an important step in enhancing care for those affected by traumatic brain injuries.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Traumatic brain injury diagnosed by computed tomography scan Glasgow coma score ≥ 4
  • Exclusion Criteria:
  • Inability to get consent. Pregnant and lactating women Traumatic subarachnoid hemorrhage Spinal cord injury Increased intra-abdominal pressure Abdominal aortic aneurysm Inferior vena cava (IVC) thrombus Portal hypertension Acute corpulmonale Congestive heart failure chronic hemodialysis Surgical intervention other than neurological one within the first 7 days Mechanical ventilation need during first 7 days Cardiac arrest during the first 7 days

About Mansoura University

Mansoura University is a prestigious academic institution located in Egypt, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, it leverages its extensive resources and expertise in various fields of healthcare to facilitate innovative research initiatives aimed at improving patient outcomes. The university collaborates with a network of healthcare professionals and researchers to conduct high-quality clinical trials, focusing on addressing critical health challenges through rigorous scientific methodologies. Its dedication to ethical research practices and adherence to regulatory standards underscores its role as a leader in the medical research community.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported